AMYLOID-BETA PROTEIN-1-42 43 (A-BETA-1-42/43) IN CEREBELLAR DIFFUSE PLAQUES - ENZYME-LINKED-IMMUNOSORBENT-ASSAY AND IMMUNOCYTOCHEMICAL STUDY/
Citation
A. Tamaoka et al., AMYLOID-BETA PROTEIN-1-42 43 (A-BETA-1-42/43) IN CEREBELLAR DIFFUSE PLAQUES - ENZYME-LINKED-IMMUNOSORBENT-ASSAY AND IMMUNOCYTOCHEMICAL STUDY/, Brain research, 679(1), 1995, pp. 151-156
Categorie Soggetti
Neurosciences
SICI code
0006-8993(1995)679:1<151:AP4(IC>2.0.ZU;2-T
Abstract
Diffuse plaques are immature and amorphous senile plaques and believed
to be in the initial phase of plaque formation. In contrast to amyloi
d angiopathy and the plaque core amyloid, diffuse plaques failed to be
purified in preserved forms from the brain. Here, we studied the diff
use plaques in the cerebellar region of the Alzheimer's disease brain
based on immunocytochemistry and ELISA using two different monoclonal
antibodies specifically recognizing the carboxyl termini of A beta mol
ecules (BA27 for A beta 1-40 and BC05 for A beta 1-42/43). We found th
at the amount of A beta 1-40 was in proportion to the staining degree
on amyloid angiopathy by immunohistochemistry. We found that A beta 1-
42/43 comprised diffuse plaques as the major component in the cerebell
a of AD brains. Taking these findings into consideration, diffuse plaq
ues, the earliest pathological change in the brain with AD, are conclu
ded to be composed mainly of A beta 1-42/43, implicating the critical
importance of this kind of A beta species deposition in the pathogenes
is of AD.